Human hepatitis B immunoglobulin (pH4, Harbin Pacific)
乙型肝炎人免疫球蛋白（ph4，哈尔滨派斯菲科）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameHuman hepatitis B immunoglobulin (pH4, Harbin Pacific)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHarbin Pacific Biopharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesHarbin Pacific Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A